Page 50 - Read Online
P. 50

Page 8 of 10     Abadías-Granado et al. Plast Aesthet Res 2021;8:27  https://dx.doi.org/10.20517/2347-9264.2020.199

               Regarding non-melanoma skin cancer, a recent study investigated the microbiomes of actinic keratosis
               (AK) and cutaneous squamous cell carcinoma (SCC) in immunocompetent men either longitudinally or
                             [52]
               cross-sectionally . Propionibacterium and Malassezia were relatively most frequently found in healthy
               perilesional areas, whereas Staphylococcus was more abundant in both AK and SCC, with a predominance
               of the S. aureus species. Particularly, eleven Operational Taxonomic Units (OTUs) of S. aureus were
               identified in the participating subjects; six of these were significantly associated with SCCs, with OTUs 50
               and 216 present in all patients, suggesting their specific involvement in progression from AK to SCC .
                                                                                                       [52]
               Lately, these results have been confirmed, finding an overabundance of S. aureus in SCC and AK compared
               with basal cell carcinoma samples. Consequently, as Malassezia was decreased in SCCs, it is hypothesized
                                                                         [53]
               that this yeast could be protective against S. aureus over-colonization  [Table 1].

               According to this local possible pathogenic effect of the skin microbiota in the promotion and/or
               progression of skin cancer, a recent study established the role of the gut microbiota in the response to anti-
               PD-1 immunotherapy in patients with metastatic melanoma. A significant association between the presence
               of some specific bacteria such as Bifidobacterium longum, Collinsella aerofaciens, and Enterococcus faecium
                                                                [54]
               and a positive clinical response to the therapy was found . According to this, reconstitution of germ-free
               mice with fecal material from responders improved tumor control, enhanced T cell responses, and
               increased efficacy of anti-PD-L1 therapy. These results suggest that commensal microbiome may modulate
               anti-tumor immunity in cancer patients .
                                                 [54]
               CONCLUSION
               Multiple studies indicate that age plays a critical role in modifying the human microbiota.


               Furthermore, it appears that the microbiota may interact with ultraviolet radiation, facilitating skin damage
               and skin cancer or protecting against them. This knowledge opens the possibility of modulating the
               microbiota to maintain or improve health during aging. Thus, topical and oral probiotics are a promising
               therapy in the prevention of premature skin aging.

               DECLARATIONS
               Authors’ contributions
               Conceptualization, investigation, writing original draft: Abadías-Granado I
               Investigation, writing original draft: Sánchez-Bernal J
               Conceptualization, supervision, writing, review and editing: Gilaberte Y

               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.
   45   46   47   48   49   50   51   52   53   54   55